Ascendis Pharma

Graphic of two hands shaking under a red and purple light
Biotech

In $285M deal, Novo taps Ascendis to help create monthly GLP-1

Novo Nordisk has signed a $285 million biobucks deal with Ascendis to help the Wegovy manufacturer reduce GLP-1 dosing frequency.
James Waldron Nov 4, 2024 8:43am
Graphic image of an arrow nailing the bullseye of a target

Ascendis' dwarfism drug hits in phase 3, threatens BioMarin

Sep 17, 2024 9:36am
very busy graphic of scientists working on an eye with one standing on a ladder preparing drops another set to apply a cont

Eyconis launches with $150M and Ascendis' eye disease meds

Jan 29, 2024 11:03am
Photo of two hands shaking

Ascendis sells Japan rights to Skytrofa, 2 other drugs for $70M

Nov 29, 2023 8:25am
Stop sign

FDA unexpectedly halts Ascendis' drug review

Apr 3, 2023 10:22am
topic report
Illustration connected puzzle pieces with the acronym MA

10 top M&A targets in biotech for 2023

Jan 30, 2023 3:00am